The major equity averages have just moved another leg higher. Their climb comes in the wake of another dose of pleasing data.

The ISM Service Index jumped to 56.8 in January from 52.6 in the prior month, surpassing the 53.1 that was expected, on average, among economists polled by Briefing.com.

Factory orders were less exciting. During December they increased by 1.1%, which is less than the 1.5% increase that had been widely expected.

THLD – Trade Alert
Up 90.70% in morning trading to $2.46 with 3M shares traded
Threshold is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of patients with some hematologic malignancies. Threshold Pharmaceuticals, Inc (NASDAQ: THLD) today announced that a global agreement was signed with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302, Threshold’s small molecule hypoxia-targeted drug.
To Read Full Story go to: http://www.pennytrader.com/quotes/THLD.php

********************

OSLH - News Alert
Up 31.25% in morning trading to $.168 with 650K shares traded
OSL Holdings Inc. is a holding company that will develop or acquire business units with the purpose of collecting and transmitting real-time consumer and business sales data that facilitates the ability to sell data, manage electronic marketplaces, operate real-time loyalty rewards and transact with buyers in multiple channels. OSL plans to sell data to manufactures for designated markets, such as urban retail, convenient and/or liquor stores. OSL intends to facilitate developing electronic marketplaces with real time buy-side and sell side capabilities for multiple private & public markets. It will operate a real-time loyalty rewards platform that can facilitate the earning and redemption of our currency at the point of the transaction (online, mobile, at retail) as well as on future transactions. The Company plans on leveraging these business units to connect buyers, sellers as well as channels that will clearly differentiate itself from the competitive landscape so that each venture can scale revenues and their respective offerings to their specific market(s) or across markets. OSL Holdings Inc. (OTCBB: OSLH) new division OSL Diversity Marketplace stated today that its goal is to provide business opportunities to diverse business owners throughout the United States. 
To Read Full Story go to: http://www.pennytrader.com/quotes/OSLH.php

********************

NSRS - News Alert
Up 11.46% in morning trading to $1.07 with 8M shares traded
North Springs Resources Corp. is focused on the evaluation, acquisition, exploration, and development of mineral resource properties. The Company is led by a skilled and experienced management team and independent consulting geologists with many years of experience. North Springs is committed to creating value for its shareholders by advancing its current holdings and by acquiring new properties with significant potential. North Springs Resources Corp. (OTCBB: NSRS)(Pinksheets: NSRS) announced the release of the third in a series of four anticipated videos detailing exploration and drilling at the Company’s 20% owned Goldstar/One Arm Joe Gold Project (the “Goldstar Property” or “Goldstar”) in Arizona. The new video can be viewed at the Company’s website at www.northspringsresources.com.
To Read Full Story go to: http://www.pennytrader.com/quotes/NSRS.php

********************

To Follow PennyTrader on Twitter: http://twitter.com/pennytrader

PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.

Strength among tech stocks (+0.7%) and financials (+0.8%) is helping the broad market work its way higher. Still, overall gains remain only modest.

Fed Chairman Bernanke is currently engaged in a question and answer session with members of the House Budget Committee. His prepared comments indicated that the sluggish expansion of the economy has left it vulnerable to shocks. Moreover, the slowed pace of business investment likely reflects concerns about the domestic outlook and developments in Europe. Bernanke noted, though, that such concerns are abating.

While stocks are at session highs, the Dollar Index is at its session low. It had sported a significant gain earlier this morning, but it is now flat.

HRID – Trade Alert
Up 46.75% in morning trading to $.113 with 7M shares traded
Hybrid Fuels, Inc. was incorporated in the state of Nevada in 1998 as Polo Equities.  It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies. Hybrid Fuels, Inc., (Pink Sheets: HRID) announced today that after a lengthy and heavily scrutinized review process that it has selected a state-of-the-art FDA approved laboratory to manufacture all new orders of Azul Instant™.
To Read Full Story go to: http://www.pennytrader.com/quotes/HRID.php

********************

TWWI - News Alert
Up 50% in morning trading to $.009 with 5M shares traded
Thrive World Wide is building out several distinct businesses. It is the owner of Daily Hot Deal, a Groupon-like deal-of-the-day business with video assets that include video commercials produced at no charge to the merchant who brings the company a deal offer. Daily Hot Deal puts these videos into its emails, on its website, www.dailyhotdeal.com, on its Facebook page, facebook.com/dailyhotdeal, and on its YouTube Channel, along with placing the videos on other media outlets. Thrive is in the process of creating Thrive Away, www.thriveaway.com, a web and mobile destination for consumers seeking vacations and recreational activities and for resort destinations, hotels, cruise lines and providers of recreational activities from golf and tennis, horseback riding, skiing, surfing, sailing, hunting, fishing, arts, antique collecting, wine tasting, etc. Thrive World Wide is also launching Thrive Media Group, which provides media buying and management services as well as video production branding and more. Thrive World Wide, Inc. (OTCQB: TWWI) (Pinksheets: TWWI) announced it has established a working relationship with Capital Broadcasting Group.
To Read Full Story go to: http://www.pennytrader.com/quotes/TWWI.php

********************

AXIH - News Alert
Up 16.88% in morning trading to $.90 with 200K shares traded
Axion International Holdings, Inc. develops structural building products in the United States and internationally from 100% recycled consumer and industrial plastics. It offers structural composite railroad crossties, structural composite I-beams, tongue-and-groove planking, and various sizes of boards for use in engineered design solutions, such as rail track, rail and tank bridges, pedestrian and recreation bridges, marinas, boardwalks, and bulk heading. The Company markets its structural products to the railroad industry, military, and industrial engineering and contracting firms. Axion International Holdings, Inc. was founded in 2006 and is headquartered in New Providence, New Jersey. Axion International (OTCBB: AXIH) announced today that the company has received a purchase order for their first installation of ties from another Class One Railroad.
To Read Full Story go to: http://www.pennytrader.com/quotes/AXIH.php

********************

To Follow PennyTrader on Twitter: http://twitter.com/pennytrader

PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.

Action among stocks has become choppy as traders digest a couple of doses of data.

Market participants just got their hands on the ISM Manufacturing Index for January. It came in at 54.1, which is better not quite as strong as the 54.5 that had been expected, on average, among economists polled by Briefing.com. The January reading is up from the downwardly revised 53.1 that was posted for the prior month, though.

Separately, construction spending data for December was also recently released. It showed that construction spending climbed by 1.5%, which exceeds the consensus call for an increase of just 0.4% after spending increased by a downwardly revised 0.4% in the prior month.

FLRE – Trade Alert
Up 75% in morning trading to $.007 with 7M shares traded
Flameret, Inc. has developed fire retardant products to suit a wide range of applications. These products are marketed under the brand names; Flameret, Flamex, Ultra Flamex and Impex. Flameret™ products are patented and held in the name of United American Inc. Flameret, Inc. (OTCBB: FLRE) announced today that it has received interest from a manufacturer’s representative to test its flame retardant product on uniforms that will be worn by the People’s Liberation Army.
To Read Full Story go to: http://www.pennytrader.com/quotes/FLRE.php

********************

SGMO - News Alert
Up 11.88% in morning trading to $3.86 with 250K shares traded
Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. Sangamo has a Phase 2 clinical trial and two Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS. Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, and Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced today that they have entered into a collaboration and license agreement to develop therapeutics for hemophilia and other monogenic diseases based on Sangamo’s zinc finger DNA-binding protein (ZFP) technology.  
To Read Full Story go to: http://www.pennytrader.com/quotes/SGMO.php

********************

CSOC - News Alert
Up 49.44% in morning trading to $.0269 with 2M shares traded
Caduceus Software Systems Corp. is a software company that specializes in developing an all-in-one solution for private practitioners and doctors. Caduceus Software Systems Corp. (OTCBB:CSOC) announced that it has updated its flagship product, Caduceus MMS v.1.0, in a way where it will have 4 sophisticated major security mechanisms built into the software. The Company believes these new security enhancements will greatly boost its competitive advantage and subsequent sales potential.
To Read Full Story go to: http://www.pennytrader.com/quotes/CSOC.php

********************

To Follow PennyTrader on Twitter: http://twitter.com/pennytrader

PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.

Pronounced selling pressure against energy stocks has sunk the sector for a 1.2% loss. The slide comes as shares of integrated oil giant and Dow component Exxon Mobil (XOM 83.61, -1.88) drop to a one-month low following in-line earnings results released ahead of the open.

A reversal by oil prices certainly hasn’t helped the energy sector. Oil prices had pushed above $101 per barrel earlier this morning, but the energy component has since fallen to $99.70 per barrel, which makes for a fractional loss.

VPER – Trade Alert
Up 100% in morning trading to $.0042 with 70M shares traded
Founded in September 2000 in San Diego, California, the Company has been pioneering VoIP services and technology for over 11 years and is now positioned to become an international emerging markets leader. Viper Networks, Inc. provides VoIP products and services through distributors and resellers around the world. Viper Networks, Inc. (Pink Sheets: VPER), yesterday announced that LEDs America has agreed to award the Company with complete sales and marketing export rights with 100% exclusivity for LEDs America’s LED products for the entire country of India, as well as Saudi Arabia for the next 5 years.
To Read Full Story go to: http://www.pennytrader.com/quotes/VPER.php

********************

BOCL - News Alert
Up 60.98% in morning trading to $.33 with 400K shares traded
Global NuTech, Inc. with the recently announced acquisition of International Plant Services, the Company is expanding its previously announced plans in the energy sector, driven by International Plant Services existing business in management and construction services to the world’s largest and best known energy companies in the refinery, chemical, mining and power industries.  Global NuTech, Inc. (OTCQX: BOCL) announced today that the company has acquired 100% of the stock of Houston, Texas based Texas Gulf Oil & Gas, Inc.
To Read Full Story go to: http://www.pennytrader.com/quotes/BOCL.php

********************

CTHR - News Alert
Up 15.88% in morning trading to $3.21 with 150K shares traded
Charles & Colvard, Ltd., based in the Research Triangle Park area of North Carolina, is the global sole source of moissanite, a unique, near-colorless created gemstone that is distinct from other gemstones and jewels based on its exceptional fire, brilliance, luster, durability, and rarity. Charles & Colvard Created Moissanite^® is currently incorporated into fine jewelry sold through domestic and international retailers and other sales channels. Charles & Colvard, Ltd. (NASDAQ Global Select Market: CTHR) today announced that fourth quarter 2011 preliminary net sales increased more than 90% versus the corresponding period of 2010 where sales were $3.5 million.
To Read Full Story go to: http://www.pennytrader.com/quotes/CTHR.php

********************

To Follow PennyTrader on Twitter: http://twitter.com/pennytrader

PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.

Stocks have extended their climb up from session lows, but weakness remains widespread. That said, tech stocks have made a nice run out of the red into positive territory. The sector is now up 0.1% and is the only sector sporting a gain.

Among tech stocks, Apple (AAPL 52.10, +4.82), IBM (IBM 91.83, +1.37), and Dell (DELL 16.85, +0.11) are displaying leadership. Semiconductor-related issues continue to trade with weakness, though. As such, the Philadelphia Semiconductor Index is currently down 1.4%.

TECO – Trade Alert
Up 100% in morning trading to $.092 with 20M shares traded
Treaty, an international energy company, is engaged in the acquisition, development and production of oil and natural gas.  Treaty acquires and develops oil and gas leases which have “proven but undeveloped reserves” at the time of acquisition.  These properties are not strategic to large exploration-oriented oil and gas companies.  This strategy allows Treaty to develop and produce oil and natural gas with tremendously decreased risk, cost and time involved in traditional exploration. Treaty Energy Corporation (OTCQB: TECO) today reported drilling success on its first oil well, SAN JUAN #2, in Belize, Central America.
To Read Full Story go to: http://www.pennytrader.com/quotes/TECO.php

********************

UFFC - News Alert
Up 9.37% in morning trading to $.14 with 100K shares traded
UFood Restaurant Group, Inc. is a franchisor and operator of fast-casual food service restaurants. UFood Grill offers a healthy lifestyle alternative to consumers in the fast-casual restaurant space and is positioned to become a leading player in the “better-for-you” quick-serve restaurant category. The Company is led by franchise innovator George Naddaff, who founded Boston Market and led the franchising of several companies including Sylvan Learning Center and VR Business Brokers. Mr. Naddaff also founded two of the first educational day care centers in the United States, Living and Learning Centers and Mulberry Child Care Centers, both of which were sold to KinderCare®. Mr. Naddaff has assembled a veteran management team at UFood Grill with a successful record in the franchise market. UFood Restaurant Group Inc. (OTC.BB: UFFC) announced today that the company has signed an agreement with Euro Café Corporation to create co-branded restaurant concepts.
To Read Full Story go to: http://www.pennytrader.com/quotes/UFFC.php

********************

POSC - News Alert
Up 28.57% in morning trading to $.018 with 2M shares traded
Positron Corporation is a leading molecular imaging healthcare company providing innovative nuclear medicine technologies and solutions that are reshaping the field of nuclear cardiology. Through proprietary PET imaging systems, services and radiopharmaceutical solutions, Positron enables healthcare providers to more accurately diagnose disease and improve patient outcomes while practicing cost effective medicine.  Positron has gained significant traction in a diverse industry and continues their strong commitment to excellence and advancing cardiac imaging solutions. Positron Corporation (OTCBB:POSC) Friday afternoon announced that on January 23, 2012, its wholly owned subsidiary, Manhattan Isotope Technology (MIT), received approval of its radioactive materials license amendment.  The Texas Department of State Health Services- Radiation Control Program granted the amendment approval.
To Read Full Story go to: http://www.pennytrader.com/quotes/POSC.php

********************

OTIV - News Alert
Up 13.79% in morning trading to $1.32 with 130K shares traded
On Track Innovations Ltd. (”OTI”) designs, develops and markets secure identification, payment and transaction processing technologies and solutions for use in secure ID, payment and loyalty applications based on its extensive patent and IP portfolio. OTI combines state-of-the-art, contactless microprocessor-based technologies and enabling hardware with proprietary software applications to deliver high performance, end-to-end solutions that are secure, robust and scalable. OTI solutions have been deployed around the world to address homeland security, national ID, medical ID, contactless payment and NFC (Near Field Communication) with loyalty applications, petroleum payment, parking and mass transit ticketing. OTI markets and supports its solutions through a global network of regional offices and alliances. On Track Innovations Ltd. (”OTI“) (Nasdaq:OTIV) today announced that the Ministry of Public Security of Panama has awarded OTI with a contract for the supply, design, installation and integration of systems to monitor and improve immigration verification processes and overall immigration flow.
To Read Full Story go to: http://www.pennytrader.com/quotes/OTIV.php

********************

To Follow PennyTrader on Twitter: http://twitter.com/pennytrader

PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.

Stocks continue to chop along with mixed results. Materials stocks, now up 0.3%, have been joined in positive territory by tech stocks, which are collectively up just 0.1%. Every other sector remains mired in negative territory.

The final reading on consumer sentiment for January from the University of Michigan improved to 75.0 from the 74.0 that was recored in the preliminary reading. Economists polled by Briefing.com had expected, on average, that the reading would inch up to 74.2.

HEB – Trade Alert
Up 16.72% in morning trading to $.37 with 350K shares traded
Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx’s flagship products include Alferon N Injection^(R) (FDA approved for a category of sexually transmitted diseases) and the experimental therapeutics Ampligen^(R) and Alferon^(R) LDO. Ampligen^(R) is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system. Hemispherx’s platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. Hemispherx has patents comprising its core intellectual property estate and a fully commercialized product (Alferon N Injection^(R)). The Company wholly owns and exclusively operates a GMP certified manufacturing facility in the United States for commercial products. Hemispherx Biopharma, Inc. (NYSE Amex:HEB) yesterday announced that ANMAT (Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica), the agency responsible for the national regulation of drugs, foods and medical technology in Argentina, has approved the sale and distribution of Alferon N Injection^(R) (under the brand name “Naturaferon”) in Argentina.
To Read Full Story go to: http://www.pennytrader.com/quotes/HEB.php

********************

ASTC - News Alert
Up 35% in morning trading to $.81 with 350K shares traded
Astrotech is one of the first space commerce companies and remains a strong entrepreneurial force in the aerospace industry. They are leaders in identifying, developing and marketing space technology for commercial use. Their ASO business unit serves our government and commercial satellite and spacecraft customers with pre-launch services on the eastern and western range. 1^st Detect Corporation is developing what they believe is a breakthrough mini-mass spectrometer, while Astrogenetix, Inc. is a biotechnology company utilizing microgravity as a research platform for drug discovery and development. 1^st Detect Corporation, a subsidiary of Astrotech Corporation (Nasdaq:ASTC), yesterday announced the delivery of pre-production mini-mass spectrometers to select customers for evaluation.
To Read Full Story go to: http://www.pennytrader.com/quotes/ASTC.php

********************

ROSG - News Alert
Up 15.84 % in morning trading to $.4981 with 850K shares traded
Rosetta Genomics develops and commercializes a full range of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development and commercialization of a full range of microRNA-based diagnostic tools. The Company’s miRview product line is commercially available through its Philadelphia-based CAP-accredited, CLIA-certified lab. Rosetta Genomics, Ltd. (”Rosetta”) (NASDAQ: ROSG) today announced it has sold an aggregate of $1.75 million in senior secured debentures in a private placement transaction with an accredited investor, and Rosetta has also agreed to negotiate in good faith a definitive license agreement with a designee of the holders of the debentures for an additional $1.25 million.
To Read Full Story go to: http://www.pennytrader.com/quotes/ROSG.php

********************

To Follow PennyTrader on Twitter: http://twitter.com/pennytrader

PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.

Selling pressure has picked up in recent trade, resulting in a loss for both the S&P 500 and the Nasdaq after each had traded with a solid gain in the early going. The Dow is at a session low, but it has managed to remain in positive territory with help from 3M (MMM 87.40, +0.92) and Caterpillar (CAT 112.67, +3.62), both of which bested expectations for the bottom line of their latest quarterly reports. However, their strength is being partly offset by weakness in AT&T (T 29.47, -0.74), which posted earnings that came short of the consensus estimate.

CBIS – Trade Alert
Up 14.71% in morning trading to $.05 with 5M shares traded
Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Cannabis Science, Inc. (OTCBB: CBIS) yesterday inform that the current progress and success with their numerous self-medicated cancer patients, has lead the Company to immediately begin the Investigational New Drug (IND) application process that will target cancer treatment.
To Read Full Story go to: http://www.pennytrader.com/quotes/CBIS.php

********************

ELTP - News Alert
Up 14.50% in morning trading to $.12 with 4M shares traded
Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. Elite’s strategy includes assisting partner companies in the life cycle management of products, to improve off-patent drug products, and developing generic versions of controlled release drug products with high barriers to entry. Elite Pharmaceuticals, Inc. (”Elite”) (OTCBB:ELTP) announced today that on January 23, 2012, the U.S. Food and Drug Administration approved the Company’s supplemental application for the manufacturing and packaging of Hydromorphone Hydrochloride USP 8 mg.
To Read Full Story go to: http://www.pennytrader.com/quotes/ELTP.php

********************

FEEC - News Alert
Up 12.21% in morning trading to $.339 with 650K shares traded
Based in Houston, Texas, with offices in Beijing, Kunming, and Taiyuan City, China, Far East Energy Corporation is focused on coalbed methane exploration and development in China. Far East Energy Corporation (OTCBB:FEEC) today announced positive test results from three more appraisal wells located at significant distances from the 1H Pilot Area in the Company’s Shouyang Block, continuing a series of successful appraisal wells that have revealed much of the block to be highly prospective.
To Read Full Story go to: http://www.pennytrader.com/quotes/FEEC.php

********************

To Follow PennyTrader on Twitter: http://twitter.com/pennytrader

PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.

The broad market remains in negative territory, unfased by the latest monthly pending home sales numbers. Pending home sales for December fell 3.5%, which is worse than the 3.0% decline that had been expected, on average, among economists polled by Briefing.com.

The pending home sales report is the first piece of concrete economic data released this week, but the highlighting event of today’s calendar is the FOMC Policy Statement at 2:00 PM ET.

ATTD – Trade Alert
Up 63.89% in morning trading to $.0059 with 51M shares traded
Attitude Drinks Inc. is an innovative, beverage brand development company with a pure milk recovery drink that exploits recent scientific evidence confirming the benefits of milk and protein as an exercise recovery aid. Phase III® is sold in select local, regional and national markets, including colleges, universities, convenience stores, fitness centers and gyms, as well as online. Attitude Drinks (OTC.BB: ATTD) (OTCQB: ATTD.OB) yesterday announced a sales agreement with Walgreens, of Deerfield, IL.
To Read Full Story go to: http://www.pennytrader.com/quotes/ATTD.php

********************

UFFC - News Alert
Up 19.83% in morning trading to $.145 with 800K shares traded
UFood Restaurant Group, Inc. is a franchisor and operator of fast-casual food service restaurants. UFood Grill offers a healthy lifestyle alternative to consumers in the fast-casual restaurant space and is positioned to become a leading player in the “better-for-you” quick-serve restaurant category. The Company is led by franchise innovator George Naddaff, who founded Boston Market and led the franchising of several companies including Sylvan Learning Center and VR Business Brokers. Mr. Naddaff also founded two of the first educational day care centers in the United States, Living and Learning Centers and Mulberry Child Care Centers, both of which were sold to KinderCare®. Mr. Naddaff has assembled a veteran management team at UFood Grill with a successful record in the franchise market. UFood is currently launching a growth plan to franchise nationwide. UFood Restaurant Group, Inc. (OTC.BB: UFFC) announced today that the company has signed an agreement for global military base development of 26 UFood Grill units with MBUF, LLC, a private investment group of military veterans and a subsidiary of Dark Horse Capital Partners.
To Read Full Story go to: http://www.pennytrader.com/quotes/UFFC.php

********************

CBAI - News Alert
Up 18.34% in morning trading to $.04 with 5M shares traded
Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders.  Cord Blood America, Inc. (OTC Bulletin Board: CBAI) said today reports that umbilical cord blood stem cells have been successfully used to treat individuals with type 1 diabetes, highlighting the importance of storing stem cells at birth.
To Read Full Story go to: http://www.pennytrader.com/quotes/CBAI.php

********************

To Follow PennyTrader on Twitter: http://twitter.com/pennytrader

PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.

The stock market has run into renewed selling pressure, cutting its climb short of positive territory. There isn’t any direct headline to account for the interruption.

However, the euro, which has shared a positive correlation with the stock market for several months, has paused just below the flat line after it, too, had spent most of the morning working its way up from a marked loss. The euro now trails the dollar by only 0.1%.

ECIT – Trade Alert
Up 78.11% in morning trading to $.415 with 5M shares traded
Ecoland International Inc. trades in Bat Guano, an organic fertilizer. In a growing organic foods market and gardening, the market for fertilizer has grown and makes up a growing percentage of the outdoor living market. D & R Technology Inc., a wholly owned subsidiary of Ecoland International, Inc. (OTCBB:ECIT), one of North America’s fastest growing applied-robotics companies, announced today the receipt of a tooling contract from Toyota Boshoku (Pink Sheets:TDBOF), a major tier one automotive parts supplier.
To Read Full Story go to: http://www.pennytrader.com/quotes/ECIT.php

********************

PRRY - News Alert
Up 71.43% in morning trading to $.06 with 2M shares traded
Planet Resource Recovery, Inc. is the developer, manufacturer and marketer of PetroLuxus™, a Green Technology that maximizes hydrocarbon recovery in the Oil & Gas industry. Documented well history case studies indicate deployment of PetroLuxus technologies has helped Oil & Gas Operators reduce maintenance costs and decrease downtime and increase oil recovery. Planet Resource Recovery, Inc. (Pinksheets: PRRY) announce the Company has executed a Stocking Distributor Agreement with Timberline Assets, Ltd. of Colorado to market and sell PetroLuxus™ Technology Platform products.
To Read Full Story go to: http://www.pennytrader.com/quotes/PRRY.php

********************

SAPX - News Alert
Up 11.81% in morning trading to $.5199 with 7M shares traded
Seven Arts Entertainment, Inc is the successor to Seven Arts Pictures Plc, which was founded in 2002 as an independent motion picture production and distribution company engaged in the development, acquisition, financing, production, and licensing of theatrical motion pictures for exhibition in domestic (i.e., the United States and Canada) and foreign theatrical markets, and for subsequent worldwide release in other forms of media, including home video and pay and free television. Seven Arts Entertainment Inc. (NASDAQ: SAPX) announced today that it has executed a definitive agreement with David Michery to acquire his music assets. Mr. Michery is a music industry veteran with an extensive track record of accomplishments. The acquired Michery assets are comprised of recording agreements with several artists, including two completed albums with multi-platinum artist DMX.
To Read Full Story go to: http://www.pennytrader.com/quotes/SAPX.php

********************

To Follow PennyTrader on Twitter: http://twitter.com/pennytrader

PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.

Stocks recently turned lower after failing to extend their opening climb. Financials and tech issues had been a source of leadership, but strength in the two sectors has been checked in recent trade.

The stock market’s slip comes even though the euro has continued to climb against the greenback. The euro is now up 1.3% to $1.305, which makes for its best level in nearly three weeks.

IVOB – Trade Alert
Up 55.94% in morning trading to $.0499 with 1M shares traded
INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company’s lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman’s vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology.  INVO Bioscience, Inc. (OTC BB: IVOB) Friday announced that the National Health Surveillance Agency (ANVISA) in Brazil has granted approval of the INVOcell for use as a Class II device.
To Read Full Story go to: http://www.pennytrader.com/quotes/IVOB.php

********************

LTSN - News Alert
Up 27.27% in morning trading to $.70 with 800K shares traded
LTS Nutraceuticals, Inc. develops, manufactures, markets and distributes an expanding line of unique, high-quality vitamins, vitamin boosters, dietary supplements and nutraceuticals. The products are sold throughout North America through two marketing channels: direct selling utilizing Inline Marketing™ to introduce products to the consumer and marketing products through national retail, drug and grocery chains and club stores. LTS Nutraceuticals, Inc. (OTCBB: LTSN) today announced that a clinical study was done on BioCalth® product that confirmed BioCalth’s effectiveness in repairing bone deterioration. The study was conducted by Dr. Jing Liang MD PhD, Associate Professor of Molecular & Medical Pharmacology at the David Geffen School of Medicine, UCLA. Dr. Liang has over 20 years of experience in pharmaceutical research and development.
To Read Full Story go to: http://www.pennytrader.com/quotes/LTSN.php

********************

MDCE - News Alert
Up 64.71% in morning trading to $.0028 with 6M shares traded
Medical Care Technologies Inc., through joint ventures or Chinese subsidiaries, develops a network of children’s health facilities in the larger urban areas throughout China. Services are geared towards the advancing economic middle-class and upper class Chinese families. Medical Care Technologies Inc. (OTCBB: MDCE) announced that it has closed a $130,000 loan agreement with a private Hong Kong company. Proceeds will go towards license completion and construction to operate its first children’s health and wellness center located in Dongguan, Guangdong Province, China.
To Read Full Story go to: http://www.pennytrader.com/quotes/MDCE.php

********************

To Follow PennyTrader on Twitter: http://twitter.com/pennytrader

PennyTrader.com, PO Box 791, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@PennyTrader.com.This email address is being protected from spam bots, you need Javascript enabled to view it

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on PennyTrader.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.